Ads
related to: inspire sleep apnea lawsuit
Search results
Results From The WOW.Com Content Network
The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of ...
Certain patients with obstructive sleep apnea who are deemed eligible candidates may be offered the hypoglossal nerve stimulator as an alternative. FDA-approved hypoglossal nerve neurostimulation is considered medically reasonable and necessary for the treatment of moderate to severe obstructive sleep apnea when all of the following criteria are met: [4]
Medicare may cover Inspire, a device to treat sleep apnea, if it is medically necessary. A doctor needs to demonstrate that people meet certain criteria and CPAP therapy has been ineffective.
The out-of-pocket cost for the Inspire sleep apnea implant may be: $1,796 at a hospital outpatient surgical center. $5,133 at a non-hospital surgical center.
Sleep surgery is a surgery performed to treat sleep disordered breathing. Sleep disordered breathing is a spectrum of disorders that includes snoring, upper airway resistance syndrome, and obstructive sleep apnea. These surgeries are performed by surgeons trained in otolaryngology, oral maxillofacial surgery, and craniofacial surgery.
Obstructive sleep apnea (OSA) is the most common sleep-related breathing disorder and is characterized by recurrent episodes of complete or partial obstruction of the upper airway leading to reduced or absent breathing during sleep.
Inspire Medical Systems Inc (NYSE: INSP ) has announced UnitedHealth Group Inc (NYSE: UNH ) will cover its Inspire Therapy for the treatment of obstructive sleep apnea beginning Aug. 1. “We are ...
The American Sleep Apnea Association (ASAA) is a non-profit organization founded in 1990 by persons with sleep apnea, health care providers and researchers. [2] The association offers education and advocacy services to improve the lives of sleep apnea patients.